Facilitated By

San Antonio Medical Foundation

News

  • Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib ... - StreetInsider

    Gonzalez Convention Center in San Antonio, Texas. The poster presents ... Celcuity is a clinical-stage biotechnology company focused on ...

  • The START Center for Cancer Research Expands its Capabilities to Support Early-Phase ...

    SAN ANTONIO, Dec. 10, 2024 /PRNewswire/ -- The START Center for Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.

  • Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant ... - Quantisnow

    ... SAN ANTONIO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc ... Biotechnology: Biological Products (No Diagnostic Substances). Health Care ...

  • San Antonio: An Urban Planner's Guide to the City | Planetizen

    San Antonio Texas Riverwalk at christmas nighttime. The Riverwalk in ... This has contributed greatly to innovation in the bioscience ...

  • Wobble Genomics' technology demonstrates potential in accelerating precision medicine innovations

    Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, has presented new data at the San Antonio ...